Chemoinformaics analysis of 7BETA,13-DIHYDROXYKAURENOLIDE
| Molecular Weight | 332.44 | nRot | 0 |
| Heavy Atom Molecular Weight | 304.216 | nRig | 24 |
| Exact Molecular Weight | 332.199 | nRing | 5 |
| Solubility: LogS | -4.149 | nHRing | 1 |
| Solubility: LogP | 2.379 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 55.2782 |
| nHD | 2 | BPOL | 30.6938 |
| QED | 0.528 |
| Synth | 6.157 |
| Natural Product Likeliness | 3.693 |
| NR-PPAR-gamma | 0.099 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.012 |
| Pgp-sub | 0.001 |
| HIA | 0.023 |
| CACO-2 | -5.082 |
| MDCK | 0.0000274 |
| BBB | 0.943 |
| PPB | 0.544582 |
| VDSS | 0.593 |
| FU | 0.461967 |
| CYP1A2-inh | 0.01 |
| CYP1A2-sub | 0.769 |
| CYP2c19-inh | 0.025 |
| CYP2c19-sub | 0.85 |
| CYP2c9-inh | 0.054 |
| CYP2c9-sub | 0.15 |
| CYP2d6-inh | 0.03 |
| CYP2d6-sub | 0.267 |
| CYP3a4-inh | 0.67 |
| CYP3a4-sub | 0.223 |
| CL | 8.332 |
| T12 | 0.059 |
| hERG | 0.013 |
| Ames | 0.116 |
| ROA | 0.663 |
| SkinSen | 0.017 |
| Carcinogencity | 0.128 |
| EI | 0.043 |
| Respiratory | 0.838 |
| NR-Aromatase | 0.872 |
| Antiviral | Yes |
| Prediction | 0.55394 |